ampicillin has been researched along with azlocillin in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (64.52) | 18.7374 |
1990's | 2 (6.45) | 18.2507 |
2000's | 5 (16.13) | 29.6817 |
2010's | 4 (12.90) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ankel-Fuchs, D; Berg, A; Heinisch, L; Möllmann, U; Stoiber, T; Wittmann, S | 1 |
Kwon, DH; Lu, CD | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Lim, SP; Nikaido, H | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
Verbist, L | 1 |
Tryba, M | 1 |
Grohe, K; Metzger, KG; Schacht, P; Zeiler, HJ | 1 |
Aldea, M; Ayala, JA; de Pedro, MA; Tormo, A; Vicente, M | 1 |
Busuttil, RW; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ | 1 |
Grimm, H | 1 |
Kho, P; Lindridge, MA; Livermore, DM; Moosdeen, F; Williams, JD | 1 |
Csiszár, K; Takáts, M | 1 |
Koup, JR; Wilson, CB | 1 |
Crokaert, F; Glupczynski, Y; Lismont, MJ; Van der Linden, MP; Yourassowsky, E | 1 |
Levine, PA | 1 |
Philippon, A | 1 |
Duval, J; Soussy, CJ | 1 |
Day, DL; McDonough, J; Shuster, CW; Yasinow, D | 1 |
Maskell, JP; Simpson, CN; Williams, JD | 1 |
Atkinson, B; Lorian, V | 1 |
Braveny, I; Dickert, H; Machka, K | 1 |
Barry, AL; Gavan, TL; Jones, RN; Thornsberry, C | 1 |
Farfel, L; Fogel, D; Miskin, A; Mogilner, BM | 1 |
Crokaert, F; Lismont, MJ; Van der Linden, MP; Yourassowsky, E | 1 |
Makarovskaia, LN; Markovskaia, EI; Tinker, LA; Zurabian, VA | 1 |
Makarovskaia, LN; Markovskaia, EI; Ryzhkova, VV; Tinker, LA; Zurabian, VA | 1 |
2 review(s) available for ampicillin and azlocillin
Article | Year |
---|---|
Ureidopenicillins, aztreonam, and thienamycin: efficacy as single-drug therapy of severe infections and potential as components of combined therapy.
Topics: Aminoglycosides; Ampicillin; Azlocillin; Aztreonam; Bacteria; Bacterial Infections; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Humans; Mezlocillin; Piperacillin; Pseudomonas aeruginosa; Thienamycins | 1986 |
Clinical pharmacology of extended-spectrum penicillins in infants and children.
Topics: Absorption; Adult; Ampicillin; Azlocillin; Child; Drug Administration Schedule; Half-Life; Humans; Infant; Kinetics; Mezlocillin; Piperacillin; Tissue Distribution | 1985 |
2 trial(s) available for ampicillin and azlocillin
Article | Year |
---|---|
[Potentiation of the effect of non-depolarizing muscle relaxants by acylaminopenicillins. Studies on the example of vecuronium].
Topics: Adult; Ampicillin; Anesthesia, General; Azlocillin; Drug Synergism; Electromyography; Female; Humans; Male; Mezlocillin; Naphthyridines; Neuromuscular Blocking Agents; Neuromuscular Junction; Pancuronium; Penicillins; Piperacillin; Premedication; Synaptic Transmission; Vecuronium Bromide | 1985 |
Comparison between the combination of azlocillin-gentamicin and ampicillin-gentamicin in the treatment of a nursery population.
Topics: Ampicillin; Azlocillin; Bacterial Infections; Drug Therapy, Combination; Gentamicins; Half-Life; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Kinetics; Microbial Sensitivity Tests; Penicillins; Prospective Studies; Random Allocation | 1983 |
27 other study(ies) available for ampicillin and azlocillin
Article | Year |
---|---|
Highly antibacterial active aminoacyl penicillin conjugates with acylated bis-catecholate siderophores based on secondary diamino acids and related compounds.
Topics: Amino Acids; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Catechols; Colony Count, Microbial; Gram-Negative Bacteria; Iron Chelating Agents; Microbial Sensitivity Tests; Oxazines; Penicillins; Structure-Activity Relationship | 2002 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Kinetic parameters of efflux of penicillins by the multidrug efflux transporter AcrAB-TolC of Escherichia coli.
Topics: Bacterial Outer Membrane Proteins; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Kinetics; Lipoproteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Penicillins; Plasmids | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |
Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms.
Topics: Ampicillin; Azlocillin; Gram-Negative Aerobic Bacteria; Imidazolidines; Microbial Sensitivity Tests; Penicillins; Ticarcillin | 1979 |
Assessment of the in vitro and in vivo activity of ciprofloxacin measured against current standards of therapy.
Topics: Ampicillin; Animals; Azlocillin; Blood; Ciprofloxacin; Escherichia coli; Humans; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Sisomicin; Tobramycin | 1985 |
Interaction of FtsA and PBP3 proteins in the Escherichia coli septum.
Topics: Alleles; Ampicillin; Azlocillin; Bacterial Proteins; Carrier Proteins; Cefsulodin; Escherichia coli; Escherichia coli Proteins; Hexosyltransferases; Imidazolidines; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Penicillins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Temperature | 1986 |
[Status of resistance to acylureidopenicillins].
Topics: Ampicillin; Azlocillin; Bacteria; Humans; Mezlocillin; Naphthyridines; Penicillin Resistance; Piperacillin | 1987 |
Behaviour of TEM-1 beta-lactamase as a resistance mechanism to ampicillin, mezlocillin and azlocillin in Escherichia coli.
Topics: Ampicillin; Azlocillin; beta-Lactamases; Conjugation, Genetic; Escherichia coli; Hydrolysis; Kinetics; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins | 1986 |
[Haemophilus influenzae B meningitis detected by a quick-diagnosis cerebrospinal fluid test].
Topics: Ampicillin; Azlocillin; Humans; Infant; Influenza B virus; Influenza, Human; Latex Fixation Tests; Meningitis, Haemophilus | 1986 |
Effect on growth curve patterns of brief exposure of bacteria to different concentrations of beta-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Azlocillin; Bacteria; Culture Media; Escherichia coli; Pseudomonas aeruginosa | 1985 |
The new penicillins.
Topics: Ampicillin; Azlocillin; Bacteria; Bacterial Infections; Humans; Mezlocillin; Piperacillin | 1985 |
Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Azlocillin; beta-Lactamases; Cefsulodin; Ceftazidime; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Monobactams; Naphthyridines; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Ticarcillin | 1985 |
[Development and current status of Pseudomonas aeruginosa sensitivity to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cephalosporins; Naphthyridines; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Quinolines; Thienamycins | 1984 |
Use of ureidopenicillins for selection of plasmid vector transformants in Pseudomonas aeruginosa and Pseudomonas putida.
Topics: Ampicillin; Azlocillin; Genetic Vectors; Mezlocillin; Mutation; Penicillins; Piperacillin; Plasmids; Pseudomonas; Pseudomonas aeruginosa; Ticarcillin; Transformation, Bacterial | 1984 |
The effect of clavulanic acid on the susceptibility of Bacteroides fragilis to three acyl-ureidopenicillins, ampicillin and carbenicillin.
Topics: Ampicillin; Azlocillin; Bacteroides fragilis; beta-Lactamases; Carbenicillin; Clavulanic Acid; Clavulanic Acids; Isoelectric Focusing; Mezlocillin; Microbial Sensitivity Tests; Piperacillin | 1984 |
Bactericidal effect of polymorphonuclear neutrophils on antibiotic-induced filaments of gram-negative bacilli.
Topics: Ampicillin; Anti-Bacterial Agents; Azlocillin; Cefsulodin; Cephalosporins; Escherichia coli; Humans; Mezlocillin; Neutrophils; Penicillins; Phagocytosis; Pseudomonas aeruginosa | 1984 |
In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
Topics: Ampicillin; Azlocillin; Bacteria; Bacterial Infections; Enterobacteriaceae; Humans; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin; Ticarcillin | 1980 |
In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.
Topics: Amikacin; Ampicillin; Azlocillin; Bacteria; Carbenicillin; Gentamicins; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Ticarcillin | 1980 |
Regrowth of Escherichia coli after brief exposure to different concentrations of ampicillin and azlocillin.
Topics: Ampicillin; Azlocillin; beta-Lactamases; Escherichia coli; Penicillins; Time Factors | 1981 |
[A method of sequential administration of antibiotics in preventive treatment of experimental plague in albino mice].
Topics: Ampicillin; Animals; Azlocillin; Drug Administration Schedule; Drug Therapy, Combination; Mice; Plague; Polymyxin B; Rifampin | 1994 |
[Enhancement of treatment efficacy in experimental plague by the sequential administration of antibiotics].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Azlocillin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Mice; Penicillins; Plague; Polymyxin B; Time Factors | 1996 |